• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

$995.00 – $1,995.00

Clear
SKU: KLI4862659 Categories: Diagnostics Market Research, Immunoassays, Oncology & Hematology Market Reports, Point-of-Care Diagnostics Pages: 130
  • Description
  • Table of Contents
  • Latest reports

Description

Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever.  Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require a fair amount of medical lab know-how, especially in the interpretation of the test result.

The goal is for cell phone-enabled test devices to provide primary care for underserved areas in developed countries and low income developing markets. Especially since new technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, to a remote caregiver service for consultation or to an electronic medical record.

This report, Cell Phone-Enabled Diagnostics: mHealth Applications in IVD tracks cell phone-enabled products on the market and how they will affect the existing diagnostic industry.   As part of this report’s coverage, the following is included:

  • Representative Cell Phone-Enabled Products in Diabetes, Immunoassays, Hematology, Histology and Molecular IVD.
  • Market Outlook for mHealth In IVD and The Best Areas For Commercial Success
  • Description of the Market Leaders, Organizations and Companies In This Market.
  • Government and Payer Support for mHealth
  • The Role of New technologies in the Evolution of POCT
  • Consumer, Physician and Payor Willingness
  • How Upstarts are Faring Vs. Established Products
  • Analyst Conclusions

Kalorama lead diagnostic analyst Shara Rosen, R.T., MBA presents the new developments in the convergence of IVD and mobile technologies in this unique overview of the mHealth IVD market.  The company profile chapter provides a selection of companies and organizations that are pioneering the use of specially designed digital and or wireless and cell phone-enabled test devices for clinical diagnostic applications. The most advanced applications are available for glucose self-testing and the transmission of stained slide images in histology, microbiology and hematology for remote consultation with and analysis by an expert. The following companies are profiled.

  • Accuster Technologies Pvt. Ltd.
  • AgaMatrix, Inc.
  • Alere
  • ARKRAY
  • ARUP Laboratories
  • Axxin
  • BBInternational
  • BIO-key International, Inc.
  • BodyTel Europe GmbH
  • California Institute of Technology (Caltech)
  • CellScope
  • CellScope Inc.
  • Clearbridge BioLoc Pte Ltd
  • Columbia University
  • DNAFORM
  • eSTI – (Electronic self-testing instruments)
  • Entra Health Systems
  • Freescale Semiconductor
  • Bill and Melinda Gates Foundation
  • Gene-Z
  • Genomic Health, Inc.
  • GenPrime, Inc.
  • Gentag Inc.
  • GlySens Incorporated
  • Harvard University Medical School
  • Heidelberger-Medical-Marketing GmbH (HMM GmbH)
  • HolGenTech Inc.
  • Holomic LLC (formerly Microskia)
  • Infopia Co Ltd
  • Intelligent Optical Systems, Inc.
  • Korea Advanced Institute of Science of Technology (KAIST)
  • Labonfoil Consortium
  • Leica Microsystems
  • Lifescan Inc.
  • Massachusetts General Hospital
  • MAVAND Solutions GmbH
  • MEDIWISS Analytic GmbH
  • Medtronic Inc.
  • MycroLab Pty Ltd.
  • NextLab
  • Oasis Diagnostics
  • Oasis Scientific, Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Limited
  • Sano Intelligence
  • Skannex
  • TelCare Inc.
  • Università Commerciale Luigi Bocconi
  • University of Arizona
  • University of Washington
  • X out TB

The companies selected are those that are pioneers in their field and that provide an overview of the innovations underway in cell phone-enabled diagnostics. The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author’s industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of POC tests, mobile health, decentralized healthcare and healthcare economics.

The use of cell phone-enabled diagnostics is in the earlystages of development in both developed and developing world markets. Thereforethis market analysis is somewhat speculative.In spite of the buzz about the use of cell phone-enabled test devices inmHealth, there are so many combinations of devices, applications and marketsthat the market is hard to define with precision.

Current mHealth programs that use cell phones as part of thediagnostic process (with the exception of glucose self-testing) have beeninitiated as pilot projects in developing countries with little or no concreteplans for their continuation as fully funded and government supportedhealthcare services.

Further, since much of the current mHealth products aredelivered as smartphone apps and services that are offered as part of a productoffering, it is difficult to estimate the size of the opportunity.  Nevertheless, this report takes a bold lookinto the possibilities for cell phone-enabled testing in the next five to tenyears.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
    • Market Trends

CHAPTER TWO: INTRODUCTION

  • Background
  • The Case For Cell phone-Enabled Devices
  • Consulting From Far and Wide
  • Point of View

CHAPTER THREE: ENABLING TECHNOLOGIES AND COMMERCIALIZATION ARRANGEMENTS

  • Overview
    • Definition of Cell Phone-Enabled Diagnostics
  • Advances in Microfluidics and Biosensors
  • The Interface and Communication Technologies
    • UC Davis Interface
    • Frontline SMS Medic
    • iPhones, Blackberrys and PDAs
  • Are Consumers Ready for mHealth?
    • Physician and Payor Opinion

CHAPTER FOUR: MARKET ANALYSIS – CELL PHONE-ENABLED DEVICES

  • Overview
  • Cell phone-Enabled Diagnostics For Diabetes
    • Scourge of Diabetes
    • Market Status of New Cell phone Glucose Monitors
    • Regulation
    • Diagnostics in Cars?
  • Cell phone-Enabled Rapid Immunoassays
    • Decentralized Trend
    • Lateral Flow Tests
    • Focus on Infectious Diseases
  • Cell-Phone Enabled Microscopy
    • Histology
    • Microbiology
    • Hematology
  • Cell Phone-Enabled Molecular Tests
    • Amplification
    • Nucleic Acid Lateral Flow
    • Microfluidic Cartridge-Based Approaches
  • The Commercial Outlook for Cell phone-enabled Diagnostic Devices

CHAPTER FIVE: CONCLUSION

 

CHAPTER SIX: COMPANIES AND OFFERINGS

  • Accuster Technologies Pvt. Ltd.
  • AgaMatrix, Inc.
  • Alere
  • ARKRAY
  • ARUP Laboratories
  • Axxin
  • BBInternational
  • BIO-key International, Inc.
  • BodyTel Europe GmbH
  • California Institute of Technology (Caltech)
  • CellScope
  • CellScope Inc.
  • Clearbridge BioLoc Pte Ltd
  • Columbia University
  • DNAFORM
  • eSTI – (Electronic self-testing instruments)
  • Entra Health Systems
  • Freescale Semiconductor
  • Bill and Melinda Gates Foundation
  • Gene-Z
  • Genomic Health, Inc.
  • GenPrime, Inc.
  • Gentag Inc.
  • GlySens Incorporated
  • Harvard University Medical School
  • Heidelberger-Medical-Marketing GmbH (HMM GmbH)
  • HolGenTech Inc.
  • Holomic LLC (formerly Microskia)
  • Infopia Co Ltd
  • Intelligent Optical Systems, Inc.
  • Korea Advanced Institute of Science of Technology (KAIST)
  • Labonfoil Consortium
  • Leica Microsystems
  • Lifescan Inc.
  • Massachusetts General Hospital
  • MAVAND Solutions GmbH
  • MEDIWISS Analytic GmbH
  • Medtronic Inc.
  • MycroLab Pty Ltd.
  • NextLab
  • Oasis Diagnostics
  • Oasis Scientific, Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Limited
  • Sano Intelligence
  • Skannex
  • TelCare Inc.
  • Università Commerciale Luigi Bocconi
  • University of Arizona
  • University of Washington
  • X out TB

LIST OF EXHIBITS

CHAPTER THREE: ENABLING TECHNOLOGIES AND COMMERCIALIZATION ARRANGEMENTS

  • Table 3-1: Selected Cell phone Enabled Test Devices

CHAPTER FOUR: MARKET ANALYSIS – CELL PHONE-ENABLED DEVICES

  • Table 4-1: Selected Cell phone-based Glucose Meters
  • Table 4-2: Selected Wireless Enabled Glucose Monitors, 2011
  • Table 4-3: Rapid Immunoassay Test Sales by Test Category 2011-2016, $ million
  • Table 4-4: Selected Cell phone-enabled Rapid Immunoassay Innovations
  • Table 4-5: Selected Molecular Tests And Platforms For Infectious Diseases
  • Table 4-6: Selected Cell Phone-Enabled Molecular Test Devices In Development

 

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    The U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products

    $3,000.00 – $6,000.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Hospital Acquired Infections: Testing MarketsEarly Toxicology: Markets and Approaches
Scroll to top